Fast axonal transport misregulation and Alzheimer's disease

NeuroMolecular Medicine

Volumn 2, Issue 2, 2002, Pages 89-99

  Morfini, Gerardo ^a   Pigino, Gustavo ^c   Beffert, Uwe ^b   Busciglio, Jorge ^c   Brady, Scott T ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Alzheimer's disease; CDK5; Fast axonal transport; Glycogen synthase kinase 3; GSK 3; Kinesin; Presenilins

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3; KINESIN; MICROTUBULE ASSOCIATED PROTEIN; PHOSPHATASE; PRESENILIN 1; PRESENILIN 2; TAU PROTEIN; CDK5 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; ENZYME ACTIVITY; FAST NERVE FIBER TRANSPORT; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; MODEL; NERVE FIBER TRANSPORT; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN PHOSPHORYLATION; REVIEW; ANIMAL; BRAIN; ENZYMOLOGY; METABOLISM; MICROTUBULE; NON-PROGRAMMATIC; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

NON-PROGRAMMATIC;

ALZHEIMER DISEASE; ANIMALS; AXONAL TRANSPORT; BRAIN; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KINESIN; MICROTUBULES; PHOSPHORYLATION; TAU PROTEINS;

EID: 0036043950     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/nmm:2:2:089     Document Type: Review

References (88)

1. Augustinack J. C., Schneider A., Mandelkow E. M., and Hyman B. T. (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. (Berl) 103, 26-35.
2. Bales K. R., Verina T., Dodel R. C., Du Y., Altstiel L., Bender M., et al. (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17, 263-264.
3. Baum L., Hansen L., Masliah E., and Saitoh T. (1996) Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation. Mol. Chem. Neuropathol. 29, 253-261.
4. Bian F., Nath R., Sobocinski G., Booher R. N., Lipinski W. J., Callahan M. J., et al. (2002) Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J. Comp. Neurol. 446, 257-266.
5. Bloom G. S., Richards B. W., Leopold P. L., Ritchey D. M., and Brady S. T. (1993) GTPγS inhibits organelle transport along axonal microtubules. J. Cell Biol. 120, 467-476.
6. Bowman A. B., Kamal A., Ritchings B. W., Philp A. V., McGrail M., Gindhart J. G., et al. (2000) Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein. Cell 103, 583-594.
7. Braak E., Braak H., and Mandelkow E. M. (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. (Berl) 87, 554-567.
8. Brady S. T. (1985) A novel brain ATPase with properties expected for the fast axonal transport motor. Nature 317, 73-75.
9. Brady S. T. (1995) A kinesin medley: Biochemical and functional heterogeneity. Trends Cell Biol. 5, 159-164.
10. Brady S. T. and Pfister K. K. (1991) Kinesin interactions with membrane bounded organelles in vivo and in vitro, in Motor Proteins (Kendrick-Jones J. and Cross R. A., eds.), The Company of Biologists, Ltd., Cambridge, England, Vol. 14, pp. 103-108.
11. Brady S. T. and Sperry A. O. (1995) Biochemical and functional diversity of microtubule motors in the nervous system. Curr. Opin. Neurobiol. 5, 551-558.
12. Brion J. P., Anderton B. H., Authelet M., Dayanandan R., Leroy K., Lovestone S., et al. (2001) Neurofibrillary tangles and tau phosphorylation. Biochem. Soc. Symp. 81-88.
13. Busciglio J., Lorenzo A., Yeh J., and Yankner B. A. (1995) beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.
14. Busciglio J., Yeh J., and Yankner B. A. (1993) beta-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J. Neurochem. 61, 1565-1568.
15. Cook D., Fry M. J., Hughes K., Sumathipala R., Woodgett J. R., and Dale T. C. (1996) Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C. EMBO J. 15, 4526-4536.
16. Cross D. A., Watt P. W., Shaw M., van der Kaay J., Downes C. P., Holder J. C., et al. (1997) Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett. 406, 211-215.
17. Cyr J. L. and Brady S. T. (1992) Molecular motors in axonal transport: cellular and molecular biology of kinesin. Mol. Neurobiol. 6, 137-156.
18. Cyr J. L., Pfister K. K., Bloom G. S., Slaughter C. A., and Brady S. T. (1991) Molecular genetics of kinesin light chains: Generation of isoforms by alternative splicing. Proc. Natl. Acad. Sci. USA 88, 10,114-10,118.
19. Eldar-Finkelman, H. (2002) Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol. Med. 8, 126-132.
20. Eldar-Finkelman H., Schreyer S. A., Shinohara M. M., LeBoeuf R. C., and Krebs E. G. (1999) Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 48, 1662-1666.
21. Elluru R., Bloom G. S., and Brady S. T. (1995) Fast axonal transport of kinesin in the rat visual system: functionality of the kinesin heavy chain isoforms. Mol. Biol. Cell 6, 21-40.
22. Elyaman W., Terro F., Wong N. S., and Hugon J. (2002) In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation. Eur. J. Neurosci. 15, 651-660.
23. Ferreira A., Niclas J., Vale R. D., Banker G., and Kosik K. S. (1992) Suppression of kinesin expression in cultured hippocampal neurons using antisense oligonucleotides. J. Cell Biol. 117, 595-606.
24. Flaherty D. B., Soria J. P., Tomasiewicz H. G., and Wood J. G. (2000) Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants. J. Neurosci. Res. 62, 463-472.
25. Furukawa K., D'Souza I., Crudder C. H., Onodera H., Itoyama Y., Poorkaj P., et al. (2000) Pro-apoptotic effects of tau mutations in chromosome 17 frontotemporal dementia and parkinsonism. Neuroreport 11, 57-60.
26. Gonzalez-Yanes C. and Sanchez-Margalet V. (2001) Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes. Biochem. Biophys. Res. Commun. 289, 282-287.
27. Gotz J. (2001) Tau and transgenic animal models. Brain Res. Brain Res. Rev. 35, 266-286.
28. Gotz J., Barmettler R., Ferrari A., Goedert M., Probst A., and Nitsch R. M. (2000) In vivo analysis of wild-type and FTDP-17 tau transgenic mice. Ann. NY Acad. Sci. 920, 126-133.
29. Haass C. and De Strooper B. (1999) The presenilins in Alzheimer's disease - proteolysis holds the key. Science 286, 916-919.
30. Hanger D. P., Hughes K., Woodgett J. R., Brion J. P., and Anderton B. H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62.
31. Harada A., Oguchi K., Okabe S., Kuno J., Terada S., Ohshima T., et al. (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369, 488-491.
32. Hirokawa N. (1998) Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 279, 519-526.
33. Hollenbeck P. J. (1990) Kinesin heavy and light chains are phosphorylated in vivo in neurons. J. Cell Biol. 115, 390a (abstract).
34. Houlden H., Baker M., Adamson J., Grover A., Waring S., Dickson D., et al. (1999) Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann. Neurol. 46, 243-248.
35. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., and Kikuchi A. (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J. 17, 1371-1384.
36. Ishiguro K., Shiratsuchi A., Sato S., Omori A., Arioka M., Kobayashi S., et al. (1993) Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett. 325, 167-172.
37. Ivaska J., Nissinen L., Immonen N., Eriksson J., Kahari V. M., and Heino J. (2002) Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta. Mol. Cell Biol. 22, 1352-1359.
38. Jackson G. R., Wiedau-Pazos M., Sang T. K., Wagle N., Brown C. A., Massachi S., et al. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in drosophila. Neuron 34, 509-519.
39. Kamal A., Almenar-Queralt A., LeBlanc J. F., Roberts E. A., and Goldstein L. S. (2001) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414, 643-648.
40. Kamal A., Stokin G. B., Yang Z., Xia C. H., and Goldstein L. S. (2000) Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28, 449-459.
41. Khodjakov A., Lizunova E. M., Minin A. A., Koonce M. P., and Gyoeva F. K. (1998) A specific light chain of kinesin associates with mitochondria in cultured cells. Mol. Biol. Cell 9, 333-343.
42. Krylova O., Messenger M. J., and Salinas P. C. (2000) Dishevelled-1 regulates microtubule stability: a new function mediated by glycogen synthase kinase-3b. J. Cell Biol. 151, 83-94.
43. Laffont I., Takahashi M., Shibukawa Y., Honke K., Shuvaev V. V., Siest G., et al. (2002) Apolipoprotein E activates Akt pathway in neuro-2a in an isoform-specific manner. Biochem. Biophys. Res. Commun. 292, 83-87.
44. LaMonte B. H., Wallace K. E., Holloway B. A., Shelly S. S., Ascaño, J., Tokito M., et al. (2002) Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34, 715-727.
45. Lasek R. J. and Brady S. T. (1982) The Structural Hypothesis of axonal transport: Two classes of moving elements. In Axoplasmic Transport (Weiss D. G., ed.), Springer-Verlag, Berlin/Heidelberg, pp. 397-405.
46. Lasek R. J. and Brady S. T. (1984) Adenylyl imido-diphosphate (AMPPNP), a nonhydrolyzable analogue of ATP, produces a stable intermediate in the motility cycle of fast axonal transport. Biol. Bull. 167, 503.
47. Lasek R. J. and Brady S. T. (1985) Attachment of transported vesicles to microtubules in axoplasm is facilitated by AMP-PNP. Nature 316, 645-647.
48. Lee K.-D. and Hollenbeck, P. J. (1995) Phosphorylation of kinesin in vivo correlates with organelle association and neurite outgrowth. J. Biol. Chem. 270, 5600-5605.
49. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., et al. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405.
50. Li B. S., Daniels M. P., and Pant H. C. (2001) Integrins stimulate phosphorylation of neurofilament NF-M subunit KSP repeats through activation of extracellular regulated-kinases (Erk1/Erk2) in cultured motoneurons and transfected NIH 3T3 cells. J. Neurochem. 76, 703-710.
51. Li B. S., Zhang L., Takahashi S., Ma W., Jaffe H., Kulkarni A. B., et al. (2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 21, 324-333.
52. Lovestone S., Hartley C. L., Pearce J., and Anderton B. H. (1996) Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience 73, 1145-1157.
53. Lucas J. J., Hernandez F., Gomez-Ramos P., Moran M. A., Hen R., and Avila J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 20, 27-39.
54. Mandelkow E. (1999) Alzheimer's disease. The tangled tale of tau. Nature 402, 588-589.
55. Mandelkow E., Song Y. H., Schweers O., Marx A., and Mandelkow E. M. (1995) On the structure of microtubules, tau, and paired helical filaments. Neurobiol. Aging 16, 347-354.
56. Mandelkow E. M., Drewes G., Biernat J., Gustke N., Van Lint J., Vandenheede J. R., et al. (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 314, 315-321.
57. Marambaud P., Alves da Costa C., Ancolio K., and Checler F. (1998) Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPalpha secretion: control by the proteasome. Biochem. Biophys. Res. Commun. 252, 134-138.
58. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
59. McGuinness T. L., Brady S. T., Gruner J., Sugimori M., Llinas R., and Greengard P. (1989) Phosphorylation-dependent inhibition by synapsin I of organelle movement in squid axoplasm. J. Neurosci. 9, 4138-4149.
60. Morfini G., Quiroga S., Rosa A., Kosik K., and Caceres A. (1997) Suppression of KIF2 in PC12 cells alters the distribution of a growth cone nonsynaptic membrane receptor and inhibits neurite extension. J. Cell Biol. 138, 657-669.
61. Morfini G., Szebenyi G., Elluru R., Ratner N., and Brady S. T. (2002) Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 23, 281-293.
62. Morfini G., Szebenyi G., Richards B., and Brady S. T. (2001) Regulation of kinesin: implications for neuronal development. Dev. Neurosci. 23, 364-376.
63. Morfini G., Tsai M., Szebenyi G., and Brady S. T. (2000) Approaches to study interactions between kinesin motors and membranes, in Kinesin Protocols (Vernos I., ed.), Humana Press, Totowa, NJ, Vol. 164, pp. 147-162.
64. Morris J. C. and Price A. L. (2001) Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 17, 101-118.
65. Naruse S., Thinakaran G., Luo J. J., Kusiak J. W., Tomita T., Iwatsubo T., et al. (1998) Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21, 1213-1221.
66. Pei J. J., Tanaka T., Tung Y. C., Braak E., Iqbal K., and Grundke-Iqbal I. (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J. Neuropathol. Exp. Neurol. 56, 70-78.
67. Pigino G., Pelsman A., Mori H., and Busciglio J. (2001) Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J. Neurosci. 21, 834-842.
68. Plyte S. E., Hughes K., Nikolakaki E., Pulverer B. J., and Woodgett J. R. (1992) Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta 1114, 147-162.
69. Ratner N., Bloom G. S., and Brady S. T. (1998) A role for Cdk5 kinase in fast anterograde axonal transport: novel effects of olomoucine and the APC tumor suppressor protein. J. Neurosci. 18, 7717-7726.
70. Saxton W. M., Hicks J., Goldstein L. S. B., and Raff E. C. (1991) Kinesin heavy chain is essential for viability and neuromuscular functions in Drosophila, but mutants show no defects in mitosis. Cell 64, 1093-1102.
71. Sperber B. R., Leight S., Goedert M., and Lee V. M. (1995) Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci. Lett. 197, 149-153.
72. Stenoien D. S. and Brady S. T. (1997) Immunochemical analysis of kinesin light chain function. Mol. Biol. Cell 8, 675-689.
73. Su J. H., Nichol K. E., Sitch T., Sheu P., Chubb C., Miller B. L., et al. (2000) DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia. Exp. Neurol. 163, 9-19.
74. Summers S. A., Kao A. W., Kohn A. D., Backus G. S., Roth R. A., Pessin J. E., et al. (1999) The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism. J. Biol. Chem. 274, 17,934-17,940.
75. Sun W., Qureshi H. Y., Cafferty P. W., Sobue K., Agarwal-Mawal A., Neufield K. D., et al. (2002) Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules. J. Biol. Chem. 277, 11,933-11,940.
76. Takashima A., Honda T., Yasutake K., Michel G., Murayama O., Murayama M., et al. (1998) Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 31, 317-323.
77. Tanaka Y., Kanai Y., Okada Y., Nonaka S., Takeda S., Harada A., et al. (1998) Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria. Cell 93, 1147-1158.
78. Tsai M.-Y., Morfini G., Szebenyi G., and Brady S. T. (2000) Modulation of kinesin-vesicle interactions by Hsc70: implications for regulation of fast axonal transport. Mol. Biol. Cell 11, 2161-2173.
79. Vale R. D., Reese T. S., and Sheetz M. P. (1985) Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility. Cell 42, 39-50.
80. Wagner M. C., Pfister K. K., Bloom G. S., and Brady S. T. (1989) Copurification of kinesin polypeptides with microtubule-stimulated Mg-ATPase activity and kinetic analysis of enzymatic processes. Cell Motil. Cytoskelet. 12, 195-215.
81. Wang Q. M., Fiol C. J., DePaoli-Roach A. A., and Roach P. J. (1994) Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J. Biol. Chem. 269, 14,566-14,574.
82. Wittmann C. W., Wszolek M. F., Shulman J. M., Salvaterra P. M., Lewis J., Hutton M., et al. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711-714.
83. Woodgett J. R. (1994) Regulation and functions of the glycogen synthase kinase-3 subfamily. Semin. Cancer Biol. 5, 269-275.
84. Woodgett J. R. (2001) Judging a Protein by More Than Its Name: GSK-3. Science's STKE, http://stke. sciencemag.org/cgi/content/full/sigtrans;2001/100/re12.
85. Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C. A., and Imahori K. (1996) Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol. (Berl) 92, 232-241.
86. Yost C., Farr G. H. 3rd, Pierce S. B., Ferkey D. M., Chen M. M., and Kimelman D. (1998) GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell 93, 1031-1041.
87. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., et al. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105, 587-597.
88. Zheng-Fischhofer Q., Biernat J., Mandelkow E. M., Illenberger S., Godemann R., and Mandelkow E. (1998) Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur. J. Biochem. 252, 542-552.